(4-benzyloxyphenyl)oxyacetic acid chloride | 206872-00-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (4-benzyloxyphenyl)oxyacetic acid chloride
• 英文别名: 2-[4-(Phenylmethoxy)phenoxy]acetyl chloride；2-(4-phenylmethoxyphenoxy)acetyl chloride
• CAS: 206872-00-6
• 化学式: C₁₅H₁₃ClO₃
• 分子量: 276.719
• InChiKey: IFUTVMVDNKCQGH-UHFFFAOYSA-N

物化性质

• 熔点：
  152-155 °C
• 沸点：
  396.4±22.0 °C(Predicted)
• 密度：
  1.240±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (4-benzyloxyphenyl)oxyacetic acid chloride 在 甲醇 、 sodium tetrahydroborate 、 三乙胺 、 三氯氧磷 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 19.5h， 生成 1-((4-(benzyloxy)phenoxy)methyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
  参考文献：
  名称：

  含有N-甲基-d-天冬氨酸受体的GluN2C和GluN2D的四氢异喹啉基增效剂的合成及构效关系

  摘要：

  我们在这里描述了一系列四氢异喹啉的合成和评估，这些四氢异喹啉显示含有 GluN2C 或 GluN2D 亚基的 NMDA 受体的亚基选择性增强。Bischler-Napieralski 条件用于将无环酰胺转化为相应的含四氢异喹啉类似物的关键步骤。使用来自非洲爪蟾卵母细胞的双电极电压钳记录和加载有 Ca 2+敏感染料的哺乳动物 BHK 细胞的成像来评估化合物。最有效的类似物具有 EC 50300 nM 的值并显示对最大有效浓度的谷氨酸和甘氨酸的反应增强 2 倍以上，但对含有 GluN2A 或 GluN2B 亚基 AMPA、红藻氨酸和 GABA 或甘氨酸受体或各种不同类型的 NMDA 受体的反应没有影响其他潜在目标。这些化合物代表一类有效的 NMDA 受体小分子亚基选择性增效剂。

  DOI：

  10.1021/jm400177t
• 作为产物：
  描述：

  4-苯甲氧基苯氧基乙酸 在 草酰氯 作用下， 生成 (4-benzyloxyphenyl)oxyacetic acid chloride
  参考文献：
  名称：

  Structure−Activity Relationships of α-Ketooxazole Inhibitors of Fatty Acid Amide Hydrolase

  摘要：

  A systematic study of the structure-activity relationships of 2b (OL-135), a potent inhibitor of fatty acid amide hydrolase (FAAH), is detailed targeting the C2 acyl side chain. A series of aryl replacements or substituents for the terminal phenyl group provided effective inhibitors (e.g., 5c, aryl = 1- napthyl, K-i = 2.6 nM), with 5hh (aryl = 3-ClPh, K-i = 900 pM) being 5-fold more potent than 2b. Conformationally restricted C2 side chains were examined, and many provided exceptionally potent inhibitors, of which 11j (ethylbiphenyl side chain) was established to be a 750 pM inhibitor. A systematic series of heteroatoms (O, NMe, S), electron-withdrawing groups (SO, SO2), and amides positioned within and hydroxyl substitutions on the linking side chain were investigated, which typically led to a loss in potency. The most tolerant positions provided effective inhibitors (12p, 6-position S, K-i = 3 nM, or 13d, 2-position OH, K-i = 8 nM) comparable in potency to 2b. Proteome-wide screening of selected inhibitors from the systematic series of > 100 candidates prepared revealed that they are selective for FAAH over all other mammalian serine proteases.

  DOI：

  10.1021/jm061414r

文献信息

• Compounds and compositions for delivering active agents
  申请人：Gschneidner David

  公开号：US20050272638A1

  公开（公告）日：2005-12-08

  Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.

  提供用于传递活性成分的化合物和组合物。同时提供了管理和制备方法。
• COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS
  申请人：Gschneidner David

  公开号：US20070010422A1

  公开（公告）日：2007-01-11

  Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.

  提供了用于输送活性剂的化合物和组合物。同时也提供了管理和制备的方法。
• Design, synthesis and early structure–activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate
  作者：Martin Schlitzer、Markus Böhm、Isabel Sattler、Hans-Martin Dahse

  DOI：10.1016/s0968-0896(00)00138-3

  日期：2000.8

  Inhibition of the farnesylation of ras proteins has been identified as a promising target in tumor therapy. Only a few farnesyltransferase inhibitors are bisubstrate analogues displaying features of both substrates, the farnesylpyrophosphate and the C-terminal CAAX-tetrapeptide sequence of the res protein. These known bisubstrate analogues consist of an AAX-tripeptide and a farnesyl residue connected through various linkers. We have developed a class of novel compounds that mimic a bisubstrate inhibitor structure and that differ from the known ones by lacking peptidic or farnesylic substructures. Long chain fatty acids and aryl-substituted carboxylic acids were used as farnesyl surrogates. These structures were linked to isoleucine amide, benzoic acid amide, N-substituted aminobenzenesulfonamides and N-alpha-aryl-substituted methionine derivatives, respectively, which function as AA- or AAX-mimetics. (C) 2000 Elsevier Science Ltd. All rights reserved.
• US6991798B1
  申请人：——

  公开号：US6991798B1

  公开（公告）日：2006-01-31
• US7186414B2
  申请人：——

  公开号：US7186414B2

  公开（公告）日：2007-03-06